Literature DB >> 1701216

Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors.

J R Hu1, E E el-Fakahany.   

Abstract

The potency and efficacy of McN-A-343 (McN) in stimulating phosphoinositide (PI) hydrolysis were investigated in Chinese hamster ovary cells transfected with the m1 and m3 muscarinic receptor genes, in comparison with carbamylcholine (CBC). In m1 cells, CBC and McN increased PI hydrolysis by 17- and 9-fold over basal, respectively, with corresponding EC50 values of 4.2 and 4.3 microM. Whereas the maximal stimulatory response to CBC was slightly less in m3 cells (11-fold over basal), McN elicited only up to a 2-fold increase in PI hydrolysis in these cells. Competition binding data with N-[3H]methylscopolamine showed that McN had a higher affinity in m1 than in m3 cells, whereas CBC did not differentiate well between the two receptor subtypes. The partial agonistic activity of McN was demonstrated by its ability to suppress the stimulation by CBC to its own maximal response in both cell lines in a dose-dependent manner and by its low efficacy and the absence of receptor spareness. The PI response to the full agonist CBC in m3 cells was associated with a larger receptor reserve than in m1 cells. Thus, differences in receptor spareness cannot account for the apparent selectivity of McN in activating m1 muscarinic receptors. Differences in the sensitivity of m1 and m3 cells to McN were not due to differences in receptor concentration, despite the fact that the receptor density in m1 cells was 2-fold higher than in m3 cells. Our results suggest an actual selectivity (but not necessarily specificity) of the effects of McN in increasing Pl hydrolysis mediated by M1 receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701216

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

1.  Protein kinase C is involved in M1-muscarinic receptor-mediated facilitation of L-type Ca2+ channels in neurons of the major pelvic ganglion of the adult male rat.

Authors:  A Sculptoreanu; N Yoshimura; W C de Groat; G T Somogyi
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

2.  M1 and M3 muscarinic receptors in human pulmonary arteries.

Authors:  X Norel; L Walch; M Costantino; C Labat; I Gorenne; E Dulmet; F Rossi; C Brink
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

3.  Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding.

Authors:  Meredith J Noetzel; Marianne K O Grant; Esam E El-Fakahany
Journal:  Pharmacology       Date:  2009-04-28       Impact factor: 2.547

4.  Cellular mechanism of acetylcholine-induced response in dissociated outer hair cells of guinea-pig cochlea.

Authors:  S Kakehata; T Nakagawa; T Takasaka; N Akaike
Journal:  J Physiol       Date:  1993-04       Impact factor: 5.182

5.  Mapping the ligand binding pocket of the human muscarinic cholinergic receptor Hm1: contribution of tyrosine-82.

Authors:  V Drübbisch; J Lameh; M Philip; Y K Sharma; W Sadée
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

6.  Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.

Authors:  N A Sharif; G W Williams; L M DeSantis
Journal:  Neurochem Res       Date:  1995-06       Impact factor: 3.996

7.  Human muscarinic receptors expressed in A9L and CHO cells: activation by full and partial agonists.

Authors:  M H Richards; P L van Giersbergen
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

8.  The spinal antinociceptive effects of cholinergic drugs in rats: receptor subtype specificity in different nociceptive tests.

Authors:  Michael Lograsso; Ray Nadeson; Colin S Goodchild
Journal:  BMC Pharmacol       Date:  2002-11-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.